Dispute with Sanofi settled, Panacea scrip soars to over 3-yr high

Panacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involved Panacea's claim that Sanofi's Shan6 vaccine infringed on its EasySix patent. Sanofi agreed not to market the infringing product and withdrew its opposition to Panacea's patent amendment.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/adExQTr
via IFTTT